Toxicologic Pathology
Nonclinical Safety Assessment, Second Edition
2nd Edition
Published on 27. August 2018
Book
Hardback
1244 pages
978-1-4987-4530-7 (ISBN)
Description
Following the success of the first edition, this book is designed to provide practical and timely information for toxicologic pathologists working in pharmaceutical drug discovery and development. The majority of the book (Organ Systems) will provide detailed descriptions of histopathological lesions observed in drug development. In addition, it will provide information to assist the pathologist in making determinations of the origin of lesions as well as its relevance to human risk.
Toxicologic Pathology: Nonclinical Safety Assessment, Second Edition includes 2 new concept chapters. The first of the new chapters address approaches for the evaluation of unique therapeutic modalities such as cell therapies, gene therapies, and gene expression knockdown therapies. While these still represent new developing therapeutic approaches, there has been significant experience with the therapeutic modalities in the last 5 years. The second new chapter addresses the nonclinical safety assessment of medical devices, a topic of increasing importance that was not addressed in a unique chapter in the first edition. The other concept chapters have been updated and cover important topics including the overview of drug development; principles of nonclinical safety assessment; an introduction to toxicologic pathology; techniques used in toxicologic pathology, clinical pathology, toxicokinetics, and drug development toxicogenomics; and spontaneous lesions.
The 13 organ system chapters provide the specifics related to pathologic characteristics, differential diagnosis, and interpretation of toxic responses in each organ system. These chapters are specifically important for the bench pathologist but also for the toxicologist who interacts with pathologists and function as study toxicologists and project team representatives in the drug development arena.
Toxicologic Pathology: Nonclinical Safety Assessment, Second Edition includes 2 new concept chapters. The first of the new chapters address approaches for the evaluation of unique therapeutic modalities such as cell therapies, gene therapies, and gene expression knockdown therapies. While these still represent new developing therapeutic approaches, there has been significant experience with the therapeutic modalities in the last 5 years. The second new chapter addresses the nonclinical safety assessment of medical devices, a topic of increasing importance that was not addressed in a unique chapter in the first edition. The other concept chapters have been updated and cover important topics including the overview of drug development; principles of nonclinical safety assessment; an introduction to toxicologic pathology; techniques used in toxicologic pathology, clinical pathology, toxicokinetics, and drug development toxicogenomics; and spontaneous lesions.
The 13 organ system chapters provide the specifics related to pathologic characteristics, differential diagnosis, and interpretation of toxic responses in each organ system. These chapters are specifically important for the bench pathologist but also for the toxicologist who interacts with pathologists and function as study toxicologists and project team representatives in the drug development arena.
Reviews / Votes
"...the editors have achieved a truly remarkable feat in pulling together over 70 of the top toxicologic pathologists, the majority of whom are still practicing in their respective fields."This book has much to recommend it to both the experienced toxicologist and toxicologic pathologist and to beginners in the field of drug development. The accumulated knowledge of the contributing authors, much of which has never been published before, makes this a classic that should be in use for many years to come."
-John R. Foster, ToxPath Sciences Ltd, Congleton, Cheshire, UK
Toxicologic Pathology 2019, Vol. 47(7) 902
Full review available at: https://journals.sagepub.com/doi/pdf/10.1177/0192623319861939 "...the editors have achieved a truly remarkable feat in pulling together over 70 of the top toxicologic pathologists, the majority of whom are still practicing in their respective fields.
"This book has much to recommend it to both the experienced toxicologist and toxicologic pathologist and to beginners in the field of drug development. The accumulated knowledge of the contributing authors, much of which has never been published before, makes this a classic that should be in use for many years to come."
-John R. Foster, ToxPath Sciences Ltd, Congleton, Cheshire, UK
Toxicologic Pathology 2019, Vol. 47(7) 902
Full review available at: https://journals.sagepub.com/doi/pdf/10.1177/0192623319861939
More details
Edition
2nd edition
Language
English
Place of publication
Bosa Roca
United States
Publishing group
Taylor & Francis Inc
Target group
Professional and scholarly
Professional Reference
Illustrations
6 s/w Abbildungen, 185 farbige Abbildungen, 50 s/w Tabellen
50 Tables, black and white; 185 Illustrations, color; 6 Illustrations, black and white
Dimensions
Height: 254 mm
Width: 178 mm
Weight
2674 gr
ISBN-13
978-1-4987-4530-7 (9781498745307)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
New editions
Page R. Bouchard | Pritam S. Sahota | Shannon Wallace
Toxicologic Pathology
Nonclinical Safety Assessment
Book
06/2025
3rd Edition
CRC Press
€352.50
Shipment within 10-20 days
Persons
On page 12
Content
Preface
Acknowledgments
Editors
Contributors
Section I Concepts in Drug Development
Chapter 1 Overview of Drug Development
James A. Popp and Jeffery A. Engelhardt
Chapter 2 Nonclinical Safety Evaluation of Drugs
Thomas M. Monticello and Jeanine L. Bussiere
Chapter 3 Nonclinical Safety Evaluation of Advanced Therapies
Timothy K. MacLachlan, Kendall S. Frazier, and Mercedes Serabian
Chapter 4 Nonclinical Safety Evaluation of Medical Devices
Kathleen A. Funk, Victoria A. Hampshire, and JoAnn C. L. Schuh
Chapter 5 Pathology and the Pathologist in Pharmaceutical Research and Development
Page R. Bouchard, Christopher J. Clarke, and Dominique Brees
Chapter 6 Routine and Special Techniques in Toxicologic Pathology
Daniel J. Patrick, Matthew L. Renninger, and Peter C. Mann
Chapter 7 Principles of Clinical Pathology
Niraj K. Tripathi and Jacqueline M. Tarrant
Chapter 8 Toxicokinetics and Drug Disposition
David D. Christ
Chapter 9 Toxicogenomics in Toxicologic Pathology
Arun R. Pandiri, David E. Malarkey, and Mark J. Hoenerhoff
Chapter 10 Spontaneous Lesions in Control Animals Used in Toxicity Studies
Robert C. Johnson, Robert H. Spaet, Gitte Jeppesen, Ursula Junker, and Robert Stull
Section II Organ Systems
Chapter 11 Gastrointestinal Tract
Judit E. Markovits, Graham R. Betton, Donald N. McMartin, and Theresa Boulineau
Chapter 12 Liver, Gallbladder, and Exocrine Pancreas
Russell C. Cattley, James A. Popp, and Steven L. Vonderfecht
Chapter 13 Respiratory System
Tom P. McKevitt and David J. Lewis
Chapter 14 Urinary System
Kendall S. Frazier and John Curtis Seely
Chapter 15 Hematopoietic System
Kristin Henson, Tanasa Osborne, and Gregory S. Travlos
Chapter 16 The Lymphoid System
Patrick J. Haley
Chapter 17 Bone, Muscle, and Tooth
John L. Vahle, Joel R. Leininger, Philip H. Long, D. Greg Hall, and Heinrich Ernst
Chapter 18 The Cardiovascular System
Calvert Louden, David Brott, Chidozie J. Amuzie, Bindu Bennet, and Ronnie Chamanza
Chapter 19 Endocrine Glands
Richard A. Peterson, Sundeep Chandra, and Mark J. Hoenerhoff
Chapter 20 Reproductive System and Mammary Gland
Justin D. Vidal, Charles E. Wood, Karyn Colman, Katharine M. Whitney, and Dianne M. Creasy
Chapter 21 Skin
Zbigniew W. Wojcinski, Lydia Andrews-Jones, Daher Ibrahim Aibo, Rie Kikkawa, and Robert Dunstan
Chapter 22 Nervous System
Mark T. Butt, Alys Bradley, and Robert Sills
Chapter 23 Special Senses: Eye and Ear
Kenneth A. Schafer, Oliver C. Turner, and Richard A. Altschuler
Index
Acknowledgments
Editors
Contributors
Section I Concepts in Drug Development
Chapter 1 Overview of Drug Development
James A. Popp and Jeffery A. Engelhardt
Chapter 2 Nonclinical Safety Evaluation of Drugs
Thomas M. Monticello and Jeanine L. Bussiere
Chapter 3 Nonclinical Safety Evaluation of Advanced Therapies
Timothy K. MacLachlan, Kendall S. Frazier, and Mercedes Serabian
Chapter 4 Nonclinical Safety Evaluation of Medical Devices
Kathleen A. Funk, Victoria A. Hampshire, and JoAnn C. L. Schuh
Chapter 5 Pathology and the Pathologist in Pharmaceutical Research and Development
Page R. Bouchard, Christopher J. Clarke, and Dominique Brees
Chapter 6 Routine and Special Techniques in Toxicologic Pathology
Daniel J. Patrick, Matthew L. Renninger, and Peter C. Mann
Chapter 7 Principles of Clinical Pathology
Niraj K. Tripathi and Jacqueline M. Tarrant
Chapter 8 Toxicokinetics and Drug Disposition
David D. Christ
Chapter 9 Toxicogenomics in Toxicologic Pathology
Arun R. Pandiri, David E. Malarkey, and Mark J. Hoenerhoff
Chapter 10 Spontaneous Lesions in Control Animals Used in Toxicity Studies
Robert C. Johnson, Robert H. Spaet, Gitte Jeppesen, Ursula Junker, and Robert Stull
Section II Organ Systems
Chapter 11 Gastrointestinal Tract
Judit E. Markovits, Graham R. Betton, Donald N. McMartin, and Theresa Boulineau
Chapter 12 Liver, Gallbladder, and Exocrine Pancreas
Russell C. Cattley, James A. Popp, and Steven L. Vonderfecht
Chapter 13 Respiratory System
Tom P. McKevitt and David J. Lewis
Chapter 14 Urinary System
Kendall S. Frazier and John Curtis Seely
Chapter 15 Hematopoietic System
Kristin Henson, Tanasa Osborne, and Gregory S. Travlos
Chapter 16 The Lymphoid System
Patrick J. Haley
Chapter 17 Bone, Muscle, and Tooth
John L. Vahle, Joel R. Leininger, Philip H. Long, D. Greg Hall, and Heinrich Ernst
Chapter 18 The Cardiovascular System
Calvert Louden, David Brott, Chidozie J. Amuzie, Bindu Bennet, and Ronnie Chamanza
Chapter 19 Endocrine Glands
Richard A. Peterson, Sundeep Chandra, and Mark J. Hoenerhoff
Chapter 20 Reproductive System and Mammary Gland
Justin D. Vidal, Charles E. Wood, Karyn Colman, Katharine M. Whitney, and Dianne M. Creasy
Chapter 21 Skin
Zbigniew W. Wojcinski, Lydia Andrews-Jones, Daher Ibrahim Aibo, Rie Kikkawa, and Robert Dunstan
Chapter 22 Nervous System
Mark T. Butt, Alys Bradley, and Robert Sills
Chapter 23 Special Senses: Eye and Ear
Kenneth A. Schafer, Oliver C. Turner, and Richard A. Altschuler
Index